With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...
2 天on MSN
New atlas that charts tumor cell diversity could guide personalized therapy for head and neck cancer
Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human ...
A man successfully developed a mRNA cancer vaccine for his dog with the help of AI, and medical science is stunned.
Morning Overview on MSN
Study finds microplastics in 90% of prostate cancer tumors
Researchers at NYU Langone Health have detected tiny plastic fragments in nine out of 10 prostate cancer tumors examined, a ...
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...
For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...
Colorectal cancer (CRC) remains one of the most prevalent malignancies and a leading cause of cancer-related mortality worldwide. Beyond tumor-intrinsic ...
6 小时on MSN
'Bugs delivering drugs': A new approach to colorectal cancer treatment using common food ...
Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a ...
MedPage Today on MSN
COVID, Then Lung Cancer; Revisiting Nuclear Power and Cancer; Anti-Tumor Cherries?
News, features, and commentary about cancer-related issues ...
Spencer Laird was diagnosed with colon cancer at 26. At 30, he was told it had returned and spread to his lungs, with one tumor the size of a golf ball.
Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果